Related Experiment Video
Updated: Jul 17, 2026
10:48
Intravital Microscopy Imaging of the Liver following Leishmania Infection: An Assessment of Hepatic Hemodynamics
Published on: July 28, 2015
Visceral leishmaniasis masquerading as chronic liver disease
A Prakash1, N P Singh, G Sridhara
1Department of Medicine and Pathology, Maulana Azad Medical College and Associated Lok Nayak and GB Pant Hospitals, New Delhi.
The Journal of the Association of Physicians of India
|January 26, 2007
Summary
This case study highlights a rare presentation of visceral leishmaniasis (kala-azar) causing liver disease and portal hypertension. Early diagnosis and treatment are crucial for managing this uncommon parasitic infection.
Area of Science:
- Hepatology
- Infectious Diseases
- Parasitology
Background:
- Visceral leishmaniasis (kala-azar) is a serious parasitic disease.
- It typically affects the spleen, liver, and bone marrow.
- Unusual presentations can complicate diagnosis.
Observation:
- A patient presented with fever, jaundice, abdominal distension, ascites, and hepatosplenomegaly.
- Investigations revealed pancytopenia, abnormal liver function tests, portal hypertension, and esophageal varices.
- Liver biopsy indicated leishmanial hepatitis, and bone marrow showed Leishmania donovani (LD) bodies.
Findings:
- The patient was diagnosed with visceral leishmaniasis with leishmanial hepatitis and portal hypertension.
- This represents a rare and atypical manifestation of kala-azar.
- The combination of liver involvement and portal hypertension is particularly uncommon.
Implications:
- This case underscores the importance of considering visceral leishmaniasis in the differential diagnosis of unexplained liver dysfunction and portal hypertension.
- Recognizing unusual presentations is vital for timely and effective treatment.
- Further research into atypical leishmaniasis manifestations may improve diagnostic strategies.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...